Description

OXRA 10 MG (1X14)

Indications

OXRA 10 MG is primarily indicated for the treatment of various allergic conditions, including allergic rhinitis, conjunctivitis, and urticaria. This medication is effective in alleviating symptoms such as sneezing, itching, runny nose, and skin rashes. It is particularly beneficial for patients who experience seasonal allergies or those exposed to perennial allergens.

Mechanism of Action

OXRA 10 MG contains an active ingredient that functions as an antihistamine. It works by blocking the action of histamine, a substance in the body that is responsible for allergic symptoms. By inhibiting the H1 receptors, OXRA reduces the effects of histamine, thereby providing relief from allergic symptoms. This mechanism helps to stabilize mast cells and prevent the release of additional histamine and other inflammatory mediators.

Pharmacological Properties

OXRA exhibits a rapid onset of action, typically within one hour of administration, with a duration of effect lasting up to 24 hours. The pharmacokinetics of the drug indicate that it is well-absorbed from the gastrointestinal tract, with peak plasma concentrations reached within 1 to 2 hours. It is metabolized in the liver and primarily excreted through the urine. The drug demonstrates a favorable safety profile, with minimal sedative effects compared to first-generation antihistamines.

Contraindications

OXRA 10 MG is contraindicated in patients with known hypersensitivity to the active ingredient or any of the excipients in the formulation. Additionally, it should not be used in individuals with severe liver impairment or those with a history of angle-closure glaucoma. Caution is advised in patients with urinary retention or prostatic hypertrophy, as antihistamines may exacerbate these conditions.

Side Effects

Common side effects associated with OXRA 10 MG include drowsiness, dry mouth, dizziness, and gastrointestinal disturbances such as nausea. While most patients tolerate the medication well, some may experience more severe reactions, including allergic reactions, tachycardia, or blurred vision. If any serious side effects occur, patients should seek immediate medical attention.

Dosage and Administration

The typical adult dosage of OXRA 10 MG is one tablet taken once daily. For children aged 6 to 12 years, the recommended dosage is half a tablet (5 MG) once daily. It is advisable to take the medication at the same time each day to maintain consistent blood levels. Patients should follow their healthcare provider’s recommendations regarding dosage adjustments based on individual response and tolerability.

Interactions

OXRA 10 MG may interact with other medications, particularly those that have sedative properties, such as benzodiazepines, opioids, and alcohol. The concomitant use of these substances can enhance the sedative effects of OXRA, leading to increased drowsiness and impaired cognitive function. Additionally, certain antifungal medications and antibiotics may affect the metabolism of OXRA, necessitating dosage adjustments. Patients should inform their healthcare provider of all medications they are currently taking to avoid potential interactions.

Precautions

Before starting treatment with OXRA 10 MG, patients should inform their healthcare provider about any pre-existing medical conditions, particularly liver disease, cardiovascular disorders, or respiratory issues such as asthma. Special caution is warranted in elderly patients, who may be more susceptible to the side effects of antihistamines. It is also advisable for patients to avoid operating heavy machinery or driving until they know how OXRA affects them, particularly during the initial stages of treatment.

Clinical Studies

Clinical studies have demonstrated the efficacy of OXRA 10 MG in managing allergic symptoms. In a randomized, double-blind, placebo-controlled trial, patients receiving OXRA reported significant improvements in nasal congestion, sneezing, and itching compared to those receiving a placebo. Furthermore, long-term studies have indicated that OXRA maintains its efficacy without significant tolerance development over extended periods of use. These findings support the use of OXRA as a first-line treatment for allergic conditions.

Conclusion

OXRA 10 MG is a well-established antihistamine that provides effective relief from allergic symptoms. With its favorable pharmacokinetic profile and minimal sedative effects, it is suitable for both adults and children. Patients should adhere to the prescribed dosage and be aware of potential interactions and side effects. Regular consultations with healthcare providers are essential to ensure optimal management of allergic conditions and to address any concerns that may arise during treatment.